Catégories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
715
Aroma Chemicals
203
Biochemicals
1003
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
89
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
Rivaroxaban
(89987190 | 366789-02-8)
CAS: | 366789-02-8 |
---|---|
Formule moléculaire: | C19H18ClN3O5S |
Masse moléculaire: | 435.8813 |
Disponibilité: | Vérifier la disponibilité |
---|---|
Téléchargements: | | |
89987190-1g | 1g | £66.80 | |
Commande en vrac |
89987190-1g | 1g | €93.60 | |
Commande en vrac |
89987190-1g | 1g | $100.20 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 89987190 | ||||
Product Name | Rivaroxaban | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 366789-02-8 | ||||
Molecular Formula | C19H18ClN3O5S | ||||
Molecular Weight | 435.8813 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29419000 |
Spécifications du produit
Melting Point | 228 - 231 Deg C | ||||
Heavy metals | 10ppm max | ||||
Loss on Drying | 0.5% max | ||||
Assay | 99.5% min | ||||
Residue on Ignition | 0.1% max | ||||
Individual impurity | 0.1% max | ||||
Appearance | Pale white or white powder | ||||
Enantiomeric impurity | 0.1% max |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|